Resolution of Fenfluramine-associated pulmonary arterial hypertension in Lennox-Gastaut syndrome: A case report and literature review

Fenfluramine is a medication originally approved for weight loss before being withdrawn for an association with the development of pulmonary arterial hypertension (PAH) and cardiac valvulopathy. Interest in fenfluramine at lower doses has re-emerged for treatment of drug-resistant epilepsy (DRE). He...

詳細記述

書誌詳細

主要な著者:	Rebecca Strafella, Richard Wang, Marissa Petchpradub, Ariel Sacknovitz, Patricia E. McGoldrick, Steven M. Wolf
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2024-01-01
シリーズ:	Epilepsy & Behavior Reports
主題:	Drug-resistant epilepsy LGS Lennox-Gastaut Syndrome Fintepla
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S258998642400087X
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!